96 results on '"DAPTOMYCIN"'
Search Results
2. Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis (AddaMAP)
3. DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
4. PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
5. Staphylococcus Aureus Network Adaptive Platform Trial (SNAP)
6. Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
7. Comparing Oral Versus Parenteral Antimicrobial Therapy (COPAT)
8. Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) (OPTIMAL)
9. Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
10. Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)
11. Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
12. Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment
13. Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients (STOP-NT)
14. Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections (PKTOXDAP)
15. Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
16. Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI (REDS)
17. Utility Assessment of a Pharmacy-to-Dose Daptomycin
18. Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC) (DAPTOSC)
19. Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
20. Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC) (TANDEM)
21. Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
22. Catheter Related - Gram Positive Bloodstream Infections
23. A Pharmacokinetics Study of Daptomycin in Critically Ill Patients and Effects of Daptomycin on Kidney
24. Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin
25. Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia (DASH)
26. The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
27. Staphylococcus Aureus Bacteremia Antibiotic Treatment Options (SABATO)
28. Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
29. A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
30. Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
31. Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
32. Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
33. PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
34. Ceftriaxone as Home IV for Staph Infections
35. Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients (DVN)
36. Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients
37. Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
38. Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting
39. Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia (HDSAB)
40. Daptomycin in Pediatric Patients With Bacterial Meningitis
41. Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
42. Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
43. Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment (RENSE)
44. Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA (DAPHEOR1006)
45. Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
46. Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
47. Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
48. Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis (CRO-OSTEO)
49. Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
50. IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.